Read More 5 minute read Pharma Industry News Anbio Biotechnology responds to global outbreaks with chikungunya rapid test and 15-minute ultra-fast PCR system Anbio Biotechnology (NASDAQ: NNNN) launches chikungunya rapid test and 15‑minute PCR, boosting its IVD leadership and investor interest in diagnostic innovation. bySoujanya RaviAugust 9, 2025